Vistagen Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY1999 | 102.4% | 102.4% | — |
| FY2000 | 82.9% | 82.9% | — |
| FY2001 | 72.0% | 72.0% | — |
| FY2002 | 46.1% | 46.1% | — |
| FY2003 | 10.2% | 10.2% | — |
| FY2004 | 64.0% | 64.0% | — |
| FY2005 | 7.3% | 7.3% | — |
| FY2006 | 10.7% | 10.7% | — |
| FY2007 | 11.5% | 11.5% | — |
| FY2008 | 24.6% | 24.6% | — |
| FY2009 | 17.6% | 17.6% | — |
| FY2010 | 15.7% | 15.7% | — |
| FY2011 | 28.8% | 28.8% | -2,930.2% |
| FY2012 | 214.0% | 214.0% | -3,574.2% |
| FY2013 | 102.6% | 102.6% | -1,461.9% |
| FY2014 | 23.2% | 27.6% | -1,125.4% |
| FY2015 | 67.6% | 73.0% | -5,148.6% |
| FY2016 | 1,586.1% | 1,618.0% | -4,770.7% |
| FY2017 | -1,665.4% | -1,665.4% | -276.3% |
| FY2018 | -207.4% | -207.4% | -127.2% |
| FY2019 | -347.5% | -347.5% | -175.5% |
| FY2020 | 362.6% | 362.6% | -359.9% |
| FY2021 | -19.5% | -19.5% | -16.6% |
| FY2022 | -73.8% | -73.8% | -64.0% |
| FY2023 | -490.5% | -490.5% | -280.9% |
| FY2024 | -25.7% | -25.7% | -23.7% |
| FY2025 | -73.0% | -73.0% | -61.0% |
| FY2026 | -196.2% | -196.2% | -143.5% |